← Eichor
Study identifier: NCT04954664 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor

Condition: Dental Implant · Bone Loss  ·  Sponsor: University of Alabama at Birmingham

PhaseNA
Planned participants44
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

This study will compare two techniques to achieve increase in ridge dimensions as a preparation for dental implants using a resorbable barrier membrane and bone particulate allogenic graft hydrated with saline or a growth factor called Recombinant Human Platelet-Derived Growth Factor (rhPDGF).

This description comes directly from the study's public registry record.

Talk to the study team

Hussein Basma, DDS, MS  ·  205-934-2888  ·  basma86@uab.edu

Sarah Startley, DMD  ·  205-975-8711  ·  ss1971@uab.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Unversity of Alabama at Birmingham, School of DentistryBirmingham, Alabama, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04954664